Restore Vision

TherapeuticsMinato-ku, Tokyo, JapanFounded 2016
Total raised
4
Rounds
Pre-Series B
Stage
Remiges Ventures
Last lead
Algorithmic summary

About Restore Vision

Restore Vision is a Therapeutics startup based in Minato-ku, Tokyo, Japansince 2016. The company reached Pre-Series B stage in 2021 with a null round led by institutional investors. Restore Vision's investor base includes 15 institutional funds, with Remiges Ventures leading the most recent equity round.

Restore Vision Inc. is a Tokyo-based biopharmaceutical startup developing gene therapy to restore vision lost to inherited retinal diseases, particularly retinitis pigmentosa. Its lead program, RV-001, uses adeno-associated virus (AAV) vectors to deliver a proprietary Chimeric Rhodopsin gene into surviving retinal interneurons via intravitreal injection, enabling patients blinded by photoreceptor loss to perceive light again. The company dosed its first patient in a Phase I/II clinical trial in February 2025 and is advancing toward global development.

Funding rounds

Restore Vision Funding Rounds Timeline

4 rounds · since 2016

RoundDateAmountValuationLead investorCo-investors
Seed2021Undisclosed
Series AJune 2023$8.9MRemiges VenturesANRI, Real Tech Fund, DBJ Capital, QB Capital, SMBC Venture Capital, Spiral Capital, Higo Bank Capital
Series A ExtensionDecember 2023$13MRemiges VenturesKyoto University Innovation Capital, JIC Venture Growth Investments, Japan Science and Technology Agency
Pre-Series BApril 2026$8.9MHigo Bank Capital, Kyoto University Innovation Capital, JIC Venture Growth Investments, Japan Science and Technology Agency, Remiges Ventures, Astellas Venture Management, Ajinomoto, Shionogi, Japan Venture Capital
Investor network

Investors in Restore Vision

15 institutional investors across 4 rounds

Lead investors

Co-investors

ANRI
series-a-2023
Real Tech Fund
series-a-2023
DBJ Capital
series-a-2023
QB Capital
series-a-2023
SMBC Venture Capital
series-a-2023
Spiral Capital
series-a-2023
Higo Bank Capital
2 rounds · series-a-2023, pre-series-b-2026
Kyoto University Innovation Capital
2 rounds · series-a-ext-2023, pre-series-b-2026
JIC Venture Growth Investments
2 rounds · series-a-ext-2023, pre-series-b-2026
Japan Science and Technology Agency
2 rounds · series-a-ext-2023, pre-series-b-2026
Astellas Venture Management
pre-series-b-2026
Ajinomoto
pre-series-b-2026
Shionogi
pre-series-b-2026
Japan Venture Capital
pre-series-b-2026
News & signals

Recent news about Restore Vision

Frequently asked

Questions about Restore Vision

How much has Restore Vision raised?

Restore Vision has raised null across 4 funding rounds since 2016.

Who are the investors of Restore Vision?

Restore Vision's investors include Remiges Ventures, ANRI, Real Tech Fund, DBJ Capital, QB Capital, SMBC Venture Capital, Spiral Capital, Higo Bank Capital, Kyoto University Innovation Capital, JIC Venture Growth Investments, Japan Science and Technology Agency, Astellas Venture Management, Ajinomoto, Shionogi, Japan Venture Capital.

When was Restore Vision's last funding round?

Restore Vision's most recent round was a null Seed in 2021.

Where is Restore Vision headquartered?

Restore Vision is headquartered in Minato-ku, Tokyo, Japan, and was founded in 2016 by Yusaku Katada.